Literature DB >> 1536742

Severe tubular resistance to aldosterone in a child with familial juvenile nephronophthisis.

B Eisenstein1, M Davidovitz, B Z Garty, D Shmueli, A Ussim, H Stark.   

Abstract

A 9.5-year-old girl, whose early symptoms were polyuria and growth retardation, is described. During the progression of her disease, hyperkalaemia developed out of proportion to the degree of renal insufficiency. Her fractional excretion of sodium increased from 3.3% to 35%, and her fractional excretion of potassium decreased from 55% to 22%. The plasma aldosterone level and plasma renin activity (PRA) were very high--290 ng/ml and 100 ng/dl per hour, respectively (normal range for this age 2.6-20.8 ng/ml and 1.2-2.7 ng/ml per hour, respectively). In an attempt to reduce these hormone levels, an acute and sustained saline load, captopril and peritoneal dialysis were used. Only the sustained saline load normalized the PRA, and only peritoneal dialysis sufficiently suppressed the plasma aldosterone level. Successful renal transplantation normalized both plasma aldosterone and PRA. This girl presents the unusual occurrence of pseudohypoaldosteronism type I, during the course of familial juvenile nephronophthisis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536742     DOI: 10.1007/bf00856835

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  8 in total

1.  Plasma renin activity in normal children: its relationship to age and rates of excretion of sodium and potassium.

Authors:  L B Hiner; A B Gruskin; H J Baluarte; M L Cote
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

2.  Plasma renin activity in healthy children.

Authors:  H P Stalker; N H Holland; J M Kotchen; T A Kotchen
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

3.  Hyperkalemia in salt-wasting nephropathy. Study of the mechanism.

Authors:  M M Popovtzer; F H Katz; W F Pinggera; J Robinette; C G Halgrimson; D E Butkus
Journal:  Arch Intern Med       Date:  1973-08

4.  Nephrono-phthisis. A uremic disease with hypotonic urine.

Authors:  L Victorin; A Ljungqvist; J Winberg; H O Akesson
Journal:  Acta Med Scand       Date:  1970-09

5.  Combined tubular dysfunction in medullary cystic disease.

Authors:  A Chagnac; D Zevin; T Weinstein; J Hirsh; J Levi
Journal:  Arch Intern Med       Date:  1986-05

6.  Clinical, pathological and genetic aspects of a form of cystic disease of the renal medulla: familial juvenile nephronophthisis (FJN).

Authors:  J J van Collenburg; M W Thompson; J Huber
Journal:  Clin Nephrol       Date:  1978-02       Impact factor: 0.975

7.  Plasma renin activity and aldosterone concentration in children.

Authors:  M J Dillon; J M Ryness
Journal:  Br Med J       Date:  1975-11-08

8.  The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents.

Authors:  G J Schwartz; L P Brion; A Spitzer
Journal:  Pediatr Clin North Am       Date:  1987-06       Impact factor: 3.278

  8 in total
  3 in total

Review 1.  Glucocorticoid and mineralocorticoid resistance.

Authors:  P A Komesaroff; M C Zennaro
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

2.  Transient pseudo-hypoaldosteronism following resection of the ileum: normal level of lymphocytic aldosterone receptors outside the acute phase.

Authors:  M C Vantyghem; C Hober; A Evrard; A Ghulam; D Lescut; A Racadot; J P Triboulet; D Armanini; J Lefebvre
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

3.  SLC30A9 mutation affecting intracellular zinc homeostasis causes a novel cerebro-renal syndrome.

Authors:  Yonatan Perez; Zamir Shorer; Keren Liani-Leibson; Pauline Chabosseau; Rotem Kadir; Michael Volodarsky; Daniel Halperin; Shiran Barber-Zucker; Hanna Shalev; Ruth Schreiber; Libe Gradstein; Evgenia Gurevich; Raz Zarivach; Guy A Rutter; Daniel Landau; Ohad S Birk
Journal:  Brain       Date:  2017-04-01       Impact factor: 13.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.